nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—HTR2A—enteric nervous system—Crohn's disease	0.0295	0.173	CbGeAlD
Pimozide—HTR2A—myenteric nerve plexus—Crohn's disease	0.0223	0.131	CbGeAlD
Pimozide—Schizophrenia—Prednisone—Crohn's disease	0.0173	0.0623	CcSEcCtD
Pimozide—Electroencephalogram abnormal—Prednisone—Crohn's disease	0.0117	0.042	CcSEcCtD
Pimozide—Faecal incontinence—Mesalazine—Crohn's disease	0.00878	0.0316	CcSEcCtD
Pimozide—CACNA1G—digestive system—Crohn's disease	0.00851	0.0499	CbGeAlD
Pimozide—CALM2—gall bladder—Crohn's disease	0.00709	0.0416	CbGeAlD
Pimozide—CALM2—mouth—Crohn's disease	0.0063	0.037	CbGeAlD
Pimozide—CALM1—mouth—Crohn's disease	0.00627	0.0368	CbGeAlD
Pimozide—Breast disorder—Mercaptopurine—Crohn's disease	0.00536	0.0193	CcSEcCtD
Pimozide—Blood disorder—Mesalazine—Crohn's disease	0.00531	0.0191	CcSEcCtD
Pimozide—Amenorrhoea—Mesalazine—Crohn's disease	0.00504	0.0181	CcSEcCtD
Pimozide—Pancytopenia—Mercaptopurine—Crohn's disease	0.00487	0.0175	CcSEcCtD
Pimozide—CYP3A5—Sulfasalazine—Crohn's disease	0.0047	0.404	CbGbCtD
Pimozide—Aplastic anaemia—Azathioprine—Crohn's disease	0.00457	0.0164	CcSEcCtD
Pimozide—CALM3—smooth muscle tissue—Crohn's disease	0.0045	0.0264	CbGeAlD
Pimozide—Abnormal dreams—Mesalazine—Crohn's disease	0.00438	0.0158	CcSEcCtD
Pimozide—Eructation—Mesalazine—Crohn's disease	0.00435	0.0157	CcSEcCtD
Pimozide—Aplastic anaemia—Mesalazine—Crohn's disease	0.00416	0.015	CcSEcCtD
Pimozide—CALM3—mammalian vulva—Crohn's disease	0.00405	0.0238	CbGeAlD
Pimozide—CALM2—epithelium—Crohn's disease	0.00367	0.0215	CbGeAlD
Pimozide—CALM1—epithelium—Crohn's disease	0.00365	0.0214	CbGeAlD
Pimozide—CALM2—smooth muscle tissue—Crohn's disease	0.00353	0.0207	CbGeAlD
Pimozide—CALM1—smooth muscle tissue—Crohn's disease	0.00352	0.0206	CbGeAlD
Pimozide—CALM2—skin of body—Crohn's disease	0.00349	0.0205	CbGeAlD
Pimozide—CALM1—skin of body—Crohn's disease	0.00347	0.0204	CbGeAlD
Pimozide—Increased appetite—Mesalazine—Crohn's disease	0.00342	0.0123	CcSEcCtD
Pimozide—Anaemia—Mercaptopurine—Crohn's disease	0.0033	0.0119	CcSEcCtD
Pimozide—Leukopenia—Mercaptopurine—Crohn's disease	0.0032	0.0115	CcSEcCtD
Pimozide—CALM2—mammalian vulva—Crohn's disease	0.00318	0.0187	CbGeAlD
Pimozide—CALM1—mammalian vulva—Crohn's disease	0.00317	0.0186	CbGeAlD
Pimozide—CYP2C19—Prednisone—Crohn's disease	0.00303	0.26	CbGbCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00302	0.0109	CcSEcCtD
Pimozide—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00294	0.0106	CcSEcCtD
Pimozide—Abdominal discomfort—Azathioprine—Crohn's disease	0.00293	0.0105	CcSEcCtD
Pimozide—Breast disorder—Mesalazine—Crohn's disease	0.00291	0.0105	CcSEcCtD
Pimozide—Pancytopenia—Azathioprine—Crohn's disease	0.0029	0.0104	CcSEcCtD
Pimozide—Cramp muscle—Mesalazine—Crohn's disease	0.0029	0.0104	CcSEcCtD
Pimozide—Skin disorder—Mercaptopurine—Crohn's disease	0.00283	0.0102	CcSEcCtD
Pimozide—Endocrine disorder—Prednisone—Crohn's disease	0.00283	0.0102	CcSEcCtD
Pimozide—CALM2—lymphoid tissue—Crohn's disease	0.00282	0.0166	CbGeAlD
Pimozide—CALM1—lymphoid tissue—Crohn's disease	0.00281	0.0165	CbGeAlD
Pimozide—CALM2—digestive system—Crohn's disease	0.00279	0.0164	CbGeAlD
Pimozide—Dysphagia—Mesalazine—Crohn's disease	0.00278	0.01	CcSEcCtD
Pimozide—Anorexia—Mercaptopurine—Crohn's disease	0.00278	0.00999	CcSEcCtD
Pimozide—CALM1—digestive system—Crohn's disease	0.00278	0.0163	CbGeAlD
Pimozide—Eosinophilia—Mesalazine—Crohn's disease	0.00275	0.0099	CcSEcCtD
Pimozide—Amenorrhoea—Prednisone—Crohn's disease	0.00267	0.0096	CcSEcCtD
Pimozide—Abdominal discomfort—Mesalazine—Crohn's disease	0.00267	0.00959	CcSEcCtD
Pimozide—HRH1—epithelium—Crohn's disease	0.00266	0.0156	CbGeAlD
Pimozide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00265	0.00955	CcSEcCtD
Pimozide—CYP2C19—digestive system—Crohn's disease	0.00265	0.0155	CbGeAlD
Pimozide—Pancytopenia—Mesalazine—Crohn's disease	0.00264	0.0095	CcSEcCtD
Pimozide—Pollakiuria—Mesalazine—Crohn's disease	0.00257	0.00924	CcSEcCtD
Pimozide—HRH1—smooth muscle tissue—Crohn's disease	0.00256	0.0151	CbGeAlD
Pimozide—Agranulocytosis—Azathioprine—Crohn's disease	0.00254	0.00914	CcSEcCtD
Pimozide—Decreased appetite—Mercaptopurine—Crohn's disease	0.00253	0.00911	CcSEcCtD
Pimozide—Weight increased—Mesalazine—Crohn's disease	0.00253	0.0091	CcSEcCtD
Pimozide—Weight decreased—Mesalazine—Crohn's disease	0.00252	0.00905	CcSEcCtD
Pimozide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00252	0.00905	CcSEcCtD
Pimozide—Depression—Mesalazine—Crohn's disease	0.00247	0.00889	CcSEcCtD
Pimozide—Cataract—Prednisone—Crohn's disease	0.00246	0.00886	CcSEcCtD
Pimozide—ABCB1—Prednisone—Crohn's disease	0.00245	0.21	CbGbCtD
Pimozide—Sweating—Mesalazine—Crohn's disease	0.00238	0.00855	CcSEcCtD
Pimozide—Agranulocytosis—Mesalazine—Crohn's disease	0.00231	0.00832	CcSEcCtD
Pimozide—HRH1—mammalian vulva—Crohn's disease	0.00231	0.0136	CbGeAlD
Pimozide—HTR2A—epithelium—Crohn's disease	0.00222	0.0131	CbGeAlD
Pimozide—Connective tissue disorder—Mesalazine—Crohn's disease	0.00219	0.00787	CcSEcCtD
Pimozide—CYP1A2—digestive system—Crohn's disease	0.00216	0.0127	CbGeAlD
Pimozide—HTR2A—smooth muscle tissue—Crohn's disease	0.00214	0.0126	CbGeAlD
Pimozide—CYP3A5—digestive system—Crohn's disease	0.00209	0.0122	CbGeAlD
Pimozide—Eye disorder—Mesalazine—Crohn's disease	0.00208	0.00748	CcSEcCtD
Pimozide—Cardiac disorder—Mesalazine—Crohn's disease	0.00207	0.00743	CcSEcCtD
Pimozide—Hyperkinesia—Prednisone—Crohn's disease	0.00205	0.00736	CcSEcCtD
Pimozide—CALM3—lymph node—Crohn's disease	0.00203	0.0119	CbGeAlD
Pimozide—HRH1—digestive system—Crohn's disease	0.00202	0.0119	CbGeAlD
Pimozide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00199	0.00717	CcSEcCtD
Pimozide—CYP2E1—lymphoid tissue—Crohn's disease	0.00197	0.0116	CbGeAlD
Pimozide—Anaemia—Azathioprine—Crohn's disease	0.00197	0.00707	CcSEcCtD
Pimozide—Mental disorder—Mesalazine—Crohn's disease	0.00195	0.00701	CcSEcCtD
Pimozide—CYP2E1—digestive system—Crohn's disease	0.00195	0.0114	CbGeAlD
Pimozide—Leukopenia—Azathioprine—Crohn's disease	0.0019	0.00685	CcSEcCtD
Pimozide—Muscle spasms—Mesalazine—Crohn's disease	0.00186	0.0067	CcSEcCtD
Pimozide—Vomiting—Mercaptopurine—Crohn's disease	0.00185	0.00666	CcSEcCtD
Pimozide—Rash—Mercaptopurine—Crohn's disease	0.00184	0.00661	CcSEcCtD
Pimozide—Dermatitis—Mercaptopurine—Crohn's disease	0.00184	0.0066	CcSEcCtD
Pimozide—Vision blurred—Mesalazine—Crohn's disease	0.00183	0.00657	CcSEcCtD
Pimozide—Tremor—Mesalazine—Crohn's disease	0.00182	0.00653	CcSEcCtD
Pimozide—Increased appetite—Prednisone—Crohn's disease	0.00181	0.00652	CcSEcCtD
Pimozide—Myalgia—Azathioprine—Crohn's disease	0.00181	0.00651	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.0018	0.00647	CcSEcCtD
Pimozide—Anaemia—Mesalazine—Crohn's disease	0.00179	0.00644	CcSEcCtD
Pimozide—Syncope—Mesalazine—Crohn's disease	0.00174	0.00625	CcSEcCtD
Pimozide—Leukopenia—Mesalazine—Crohn's disease	0.00173	0.00624	CcSEcCtD
Pimozide—Nausea—Mercaptopurine—Crohn's disease	0.00173	0.00622	CcSEcCtD
Pimozide—Palpitations—Mesalazine—Crohn's disease	0.00171	0.00616	CcSEcCtD
Pimozide—Loss of consciousness—Mesalazine—Crohn's disease	0.0017	0.00612	CcSEcCtD
Pimozide—HTR2A—digestive system—Crohn's disease	0.00169	0.00993	CbGeAlD
Pimozide—Skin disorder—Azathioprine—Crohn's disease	0.00169	0.00606	CcSEcCtD
Pimozide—Hypertension—Mesalazine—Crohn's disease	0.00167	0.00602	CcSEcCtD
Pimozide—Chest pain—Mesalazine—Crohn's disease	0.00165	0.00593	CcSEcCtD
Pimozide—Myalgia—Mesalazine—Crohn's disease	0.00165	0.00593	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00164	0.00589	CcSEcCtD
Pimozide—Hypotension—Azathioprine—Crohn's disease	0.00162	0.00583	CcSEcCtD
Pimozide—Dry mouth—Mesalazine—Crohn's disease	0.00161	0.0058	CcSEcCtD
Pimozide—CALM2—lymph node—Crohn's disease	0.00159	0.00935	CbGeAlD
Pimozide—CALM1—lymph node—Crohn's disease	0.00159	0.00931	CbGeAlD
Pimozide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00158	0.00569	CcSEcCtD
Pimozide—CYP3A4—digestive system—Crohn's disease	0.00157	0.00919	CbGeAlD
Pimozide—Shock—Mesalazine—Crohn's disease	0.00156	0.0056	CcSEcCtD
Pimozide—Nervous system disorder—Mesalazine—Crohn's disease	0.00155	0.00558	CcSEcCtD
Pimozide—Tachycardia—Mesalazine—Crohn's disease	0.00154	0.00555	CcSEcCtD
Pimozide—CYP2D6—digestive system—Crohn's disease	0.00154	0.00905	CbGeAlD
Pimozide—Skin disorder—Mesalazine—Crohn's disease	0.00154	0.00552	CcSEcCtD
Pimozide—Hyperhidrosis—Mesalazine—Crohn's disease	0.00153	0.0055	CcSEcCtD
Pimozide—Anorexia—Mesalazine—Crohn's disease	0.00151	0.00542	CcSEcCtD
Pimozide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.0015	0.00539	CcSEcCtD
Pimozide—Hypotension—Mesalazine—Crohn's disease	0.00148	0.00531	CcSEcCtD
Pimozide—CYP3A4—Prednisone—Crohn's disease	0.00147	0.126	CbGbCtD
Pimozide—ABCB1—epithelium—Crohn's disease	0.00146	0.00855	CbGeAlD
Pimozide—KCNH2—lymph node—Crohn's disease	0.00144	0.00847	CbGeAlD
Pimozide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00144	0.00518	CcSEcCtD
Pimozide—Insomnia—Mesalazine—Crohn's disease	0.00143	0.00514	CcSEcCtD
Pimozide—Somnolence—Mesalazine—Crohn's disease	0.00141	0.00506	CcSEcCtD
Pimozide—Decreased appetite—Mesalazine—Crohn's disease	0.00137	0.00494	CcSEcCtD
Pimozide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00137	0.00491	CcSEcCtD
Pimozide—Erectile dysfunction—Prednisone—Crohn's disease	0.00136	0.00487	CcSEcCtD
Pimozide—Constipation—Mesalazine—Crohn's disease	0.00135	0.00486	CcSEcCtD
Pimozide—Weight increased—Prednisone—Crohn's disease	0.00134	0.00482	CcSEcCtD
Pimozide—Weight decreased—Prednisone—Crohn's disease	0.00133	0.00479	CcSEcCtD
Pimozide—Depression—Prednisone—Crohn's disease	0.00131	0.0047	CcSEcCtD
Pimozide—ABCB1—mammalian vulva—Crohn's disease	0.00126	0.00742	CbGeAlD
Pimozide—Urticaria—Mesalazine—Crohn's disease	0.00126	0.00452	CcSEcCtD
Pimozide—Diarrhoea—Azathioprine—Crohn's disease	0.00119	0.00427	CcSEcCtD
Pimozide—Connective tissue disorder—Prednisone—Crohn's disease	0.00116	0.00416	CcSEcCtD
Pimozide—HRH1—lymph node—Crohn's disease	0.00116	0.00679	CbGeAlD
Pimozide—Dizziness—Azathioprine—Crohn's disease	0.00115	0.00413	CcSEcCtD
Pimozide—Asthenia—Mesalazine—Crohn's disease	0.00113	0.00408	CcSEcCtD
Pimozide—ABCB1—lymphoid tissue—Crohn's disease	0.00112	0.00659	CbGeAlD
Pimozide—Pruritus—Mesalazine—Crohn's disease	0.00112	0.00402	CcSEcCtD
Pimozide—ABCB1—digestive system—Crohn's disease	0.00111	0.00651	CbGeAlD
Pimozide—Vomiting—Azathioprine—Crohn's disease	0.0011	0.00397	CcSEcCtD
Pimozide—Eye disorder—Prednisone—Crohn's disease	0.0011	0.00396	CcSEcCtD
Pimozide—Rash—Azathioprine—Crohn's disease	0.00109	0.00394	CcSEcCtD
Pimozide—Dermatitis—Azathioprine—Crohn's disease	0.00109	0.00393	CcSEcCtD
Pimozide—Headache—Azathioprine—Crohn's disease	0.00109	0.00391	CcSEcCtD
Pimozide—Diarrhoea—Mesalazine—Crohn's disease	0.00108	0.00389	CcSEcCtD
Pimozide—Dizziness—Mesalazine—Crohn's disease	0.00105	0.00376	CcSEcCtD
Pimozide—Mental disorder—Prednisone—Crohn's disease	0.00103	0.00371	CcSEcCtD
Pimozide—Nausea—Azathioprine—Crohn's disease	0.00103	0.00371	CcSEcCtD
Pimozide—Vomiting—Mesalazine—Crohn's disease	0.00101	0.00362	CcSEcCtD
Pimozide—Rash—Mesalazine—Crohn's disease	0.000997	0.00359	CcSEcCtD
Pimozide—Dermatitis—Mesalazine—Crohn's disease	0.000996	0.00358	CcSEcCtD
Pimozide—Headache—Mesalazine—Crohn's disease	0.000991	0.00356	CcSEcCtD
Pimozide—Vision blurred—Prednisone—Crohn's disease	0.000966	0.00347	CcSEcCtD
Pimozide—Anaemia—Prednisone—Crohn's disease	0.000948	0.00341	CcSEcCtD
Pimozide—Agitation—Prednisone—Crohn's disease	0.000942	0.00339	CcSEcCtD
Pimozide—Nausea—Mesalazine—Crohn's disease	0.000939	0.00338	CcSEcCtD
Pimozide—Syncope—Prednisone—Crohn's disease	0.000919	0.00331	CcSEcCtD
Pimozide—Loss of consciousness—Prednisone—Crohn's disease	0.000901	0.00324	CcSEcCtD
Pimozide—Convulsion—Prednisone—Crohn's disease	0.000888	0.00319	CcSEcCtD
Pimozide—Hypertension—Prednisone—Crohn's disease	0.000885	0.00318	CcSEcCtD
Pimozide—Myalgia—Prednisone—Crohn's disease	0.000873	0.00314	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000867	0.00312	CcSEcCtD
Pimozide—Shock—Prednisone—Crohn's disease	0.000823	0.00296	CcSEcCtD
Pimozide—Nervous system disorder—Prednisone—Crohn's disease	0.00082	0.00295	CcSEcCtD
Pimozide—Tachycardia—Prednisone—Crohn's disease	0.000817	0.00294	CcSEcCtD
Pimozide—Skin disorder—Prednisone—Crohn's disease	0.000813	0.00292	CcSEcCtD
Pimozide—Hyperhidrosis—Prednisone—Crohn's disease	0.000809	0.00291	CcSEcCtD
Pimozide—Anorexia—Prednisone—Crohn's disease	0.000798	0.00287	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000762	0.00274	CcSEcCtD
Pimozide—Insomnia—Prednisone—Crohn's disease	0.000757	0.00272	CcSEcCtD
Pimozide—Decreased appetite—Prednisone—Crohn's disease	0.000727	0.00262	CcSEcCtD
Pimozide—Constipation—Prednisone—Crohn's disease	0.000715	0.00257	CcSEcCtD
Pimozide—Urticaria—Prednisone—Crohn's disease	0.000665	0.00239	CcSEcCtD
Pimozide—ABCB1—lymph node—Crohn's disease	0.000633	0.00372	CbGeAlD
Pimozide—Asthenia—Prednisone—Crohn's disease	0.0006	0.00216	CcSEcCtD
Pimozide—Pruritus—Prednisone—Crohn's disease	0.000592	0.00213	CcSEcCtD
Pimozide—Diarrhoea—Prednisone—Crohn's disease	0.000572	0.00206	CcSEcCtD
Pimozide—Dizziness—Prednisone—Crohn's disease	0.000553	0.00199	CcSEcCtD
Pimozide—Vomiting—Prednisone—Crohn's disease	0.000532	0.00191	CcSEcCtD
Pimozide—Rash—Prednisone—Crohn's disease	0.000528	0.0019	CcSEcCtD
Pimozide—Dermatitis—Prednisone—Crohn's disease	0.000527	0.0019	CcSEcCtD
Pimozide—Headache—Prednisone—Crohn's disease	0.000524	0.00188	CcSEcCtD
Pimozide—Nausea—Prednisone—Crohn's disease	0.000497	0.00179	CcSEcCtD
Pimozide—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	6.65e-05	0.000123	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTGER4—Crohn's disease	6.65e-05	0.000123	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RBX1—Crohn's disease	6.61e-05	0.000122	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RBX1—Crohn's disease	6.61e-05	0.000122	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	6.6e-05	0.000122	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	6.6e-05	0.000122	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	6.59e-05	0.000122	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	6.58e-05	0.000122	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GCKR—Crohn's disease	6.52e-05	0.000121	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL2RA—Crohn's disease	6.5e-05	0.00012	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL2RA—Crohn's disease	6.5e-05	0.00012	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—CD4—Crohn's disease	6.49e-05	0.00012	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—CD4—Crohn's disease	6.49e-05	0.00012	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	6.48e-05	0.00012	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—CD4—Crohn's disease	6.44e-05	0.000119	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTGER4—Crohn's disease	6.43e-05	0.000119	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTGER4—Crohn's disease	6.43e-05	0.000119	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	6.41e-05	0.000119	CbGpPWpGaD
Pimozide—CALM3—Signaling by NGF—IL6—Crohn's disease	6.36e-05	0.000118	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL2RA—Crohn's disease	6.35e-05	0.000118	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	6.32e-05	0.000117	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	6.29e-05	0.000117	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—CD4—Crohn's disease	6.23e-05	0.000115	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—CD4—Crohn's disease	6.23e-05	0.000115	CbGpPWpGaD
Pimozide—CALM2—Signaling by NGF—IL6—Crohn's disease	6.16e-05	0.000114	CbGpPWpGaD
Pimozide—CALM1—Signaling by NGF—IL6—Crohn's disease	6.16e-05	0.000114	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL2RA—Crohn's disease	6.13e-05	0.000114	CbGpPWpGaD
Pimozide—CALM3—Disease—SMAD3—Crohn's disease	6.12e-05	0.000113	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	6.08e-05	0.000113	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SOCS1—Crohn's disease	6.07e-05	0.000112	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—UBE2D1—Crohn's disease	5.99e-05	0.000111	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	5.99e-05	0.000111	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.98e-05	0.000111	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	5.98e-05	0.000111	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	5.97e-05	0.000111	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	5.97e-05	0.000111	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SOCS1—Crohn's disease	5.96e-05	0.00011	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL2RA—Crohn's disease	5.93e-05	0.00011	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL2RA—Crohn's disease	5.93e-05	0.00011	CbGpPWpGaD
Pimozide—CALM1—Disease—SMAD3—Crohn's disease	5.92e-05	0.00011	CbGpPWpGaD
Pimozide—CALM2—Disease—SMAD3—Crohn's disease	5.92e-05	0.00011	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	5.88e-05	0.000109	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	5.87e-05	0.000109	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—RIPK2—Crohn's disease	5.81e-05	0.000108	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—UBE2D1—Crohn's disease	5.79e-05	0.000107	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—UBE2D1—Crohn's disease	5.79e-05	0.000107	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—TYK2—Crohn's disease	5.79e-05	0.000107	CbGpPWpGaD
Pimozide—CALM3—Immune System—CRP—Crohn's disease	5.79e-05	0.000107	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	5.74e-05	0.000106	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	5.7e-05	0.000106	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—TYK2—Crohn's disease	5.69e-05	0.000105	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL3—Crohn's disease	5.66e-05	0.000105	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RIPK2—Crohn's disease	5.62e-05	0.000104	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RIPK2—Crohn's disease	5.62e-05	0.000104	CbGpPWpGaD
Pimozide—CALM2—Immune System—CRP—Crohn's disease	5.6e-05	0.000104	CbGpPWpGaD
Pimozide—CALM1—Immune System—CRP—Crohn's disease	5.6e-05	0.000104	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	5.6e-05	0.000104	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—FADS1—Crohn's disease	5.56e-05	0.000103	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	5.55e-05	0.000103	CbGpPWpGaD
Pimozide—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	5.55e-05	0.000103	CbGpPWpGaD
Pimozide—CALM3—Immune System—TLR4—Crohn's disease	5.55e-05	0.000103	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	5.53e-05	0.000102	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—JAK2—Crohn's disease	5.53e-05	0.000102	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL3—Crohn's disease	5.48e-05	0.000101	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL3—Crohn's disease	5.48e-05	0.000101	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—RASGRP1—Crohn's disease	5.48e-05	0.000101	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	5.46e-05	0.000101	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	5.45e-05	0.000101	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	5.44e-05	0.000101	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—JAK2—Crohn's disease	5.42e-05	0.0001	CbGpPWpGaD
Pimozide—CALM2—Immune System—TLR4—Crohn's disease	5.37e-05	9.94e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—TLR4—Crohn's disease	5.37e-05	9.94e-05	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	5.36e-05	9.94e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TYK2—Crohn's disease	5.34e-05	9.89e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	5.34e-05	9.89e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—ICAM1—Crohn's disease	5.32e-05	9.85e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RASGRP1—Crohn's disease	5.3e-05	9.81e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RASGRP1—Crohn's disease	5.3e-05	9.81e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TYK2—Crohn's disease	5.26e-05	9.75e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SMAD3—Crohn's disease	5.24e-05	9.71e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.23e-05	9.69e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GPX4—Crohn's disease	5.21e-05	9.65e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	5.16e-05	9.56e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SMAD3—Crohn's disease	5.15e-05	9.54e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—ICAM1—Crohn's disease	5.15e-05	9.53e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—ICAM1—Crohn's disease	5.15e-05	9.53e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—JAK2—Crohn's disease	5.1e-05	9.44e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	5.07e-05	9.38e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	5.04e-05	9.34e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GCKR—Crohn's disease	5.03e-05	9.32e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—JAK2—Crohn's disease	5.02e-05	9.3e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	4.96e-05	9.19e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SOCS1—Crohn's disease	4.96e-05	9.19e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	4.95e-05	9.17e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	4.87e-05	9.02e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL2RA—Crohn's disease	4.86e-05	8.99e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SOCS1—Crohn's disease	4.8e-05	8.89e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SOCS1—Crohn's disease	4.8e-05	8.89e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	4.78e-05	8.85e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL2RA—Crohn's disease	4.77e-05	8.83e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—ALB—Crohn's disease	4.76e-05	8.82e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—TYK2—Crohn's disease	4.73e-05	8.76e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	4.69e-05	8.69e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.66e-05	8.63e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	4.65e-05	8.61e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CXCL8—Crohn's disease	4.58e-05	8.49e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—TYK2—Crohn's disease	4.58e-05	8.48e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—TYK2—Crohn's disease	4.58e-05	8.48e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TYK2—Crohn's disease	4.51e-05	8.36e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—JAK2—Crohn's disease	4.51e-05	8.36e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TYK2—Crohn's disease	4.47e-05	8.28e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—IL6—Crohn's disease	4.42e-05	8.19e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—JAK2—Crohn's disease	4.37e-05	8.09e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—JAK2—Crohn's disease	4.37e-05	8.09e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—IL6—Crohn's disease	4.36e-05	8.07e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—TYK2—Crohn's disease	4.32e-05	8e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—JAK2—Crohn's disease	4.31e-05	7.98e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SMAD3—Crohn's disease	4.28e-05	7.93e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—JAK2—Crohn's disease	4.27e-05	7.9e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—TYK2—Crohn's disease	4.18e-05	7.74e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—TYK2—Crohn's disease	4.18e-05	7.74e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—PTGS2—Crohn's disease	4.17e-05	7.72e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SMAD3—Crohn's disease	4.14e-05	7.67e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SMAD3—Crohn's disease	4.14e-05	7.67e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—JAK2—Crohn's disease	4.12e-05	7.64e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—CXCL8—Crohn's disease	4.12e-05	7.63e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.08e-05	7.55e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IFNG—Crohn's disease	4.05e-05	7.5e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TYK2—Crohn's disease	3.99e-05	7.39e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—JAK2—Crohn's disease	3.99e-05	7.39e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—JAK2—Crohn's disease	3.99e-05	7.39e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—CXCL8—Crohn's disease	3.98e-05	7.38e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—CXCL8—Crohn's disease	3.98e-05	7.38e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2RA—Crohn's disease	3.97e-05	7.35e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	3.93e-05	7.28e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IFNG—Crohn's disease	3.92e-05	7.25e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IFNG—Crohn's disease	3.92e-05	7.25e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD4—Crohn's disease	3.91e-05	7.24e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TYK2—Crohn's disease	3.9e-05	7.22e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CXCL8—Crohn's disease	3.89e-05	7.21e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TYK2—Crohn's disease	3.86e-05	7.15e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TYK2—Crohn's disease	3.86e-05	7.15e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2RA—Crohn's disease	3.84e-05	7.11e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2RA—Crohn's disease	3.84e-05	7.11e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—JAK2—Crohn's disease	3.81e-05	7.05e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD4—Crohn's disease	3.78e-05	7e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD4—Crohn's disease	3.78e-05	7e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—STAT3—Crohn's disease	3.74e-05	6.93e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—IL6—Crohn's disease	3.74e-05	6.92e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—JAK2—Crohn's disease	3.72e-05	6.88e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—IL6—Crohn's disease	3.7e-05	6.86e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—STAT3—Crohn's disease	3.69e-05	6.83e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—JAK2—Crohn's disease	3.68e-05	6.82e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—JAK2—Crohn's disease	3.68e-05	6.82e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—IL6—Crohn's disease	3.63e-05	6.72e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL1B—Crohn's disease	3.61e-05	6.69e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—CD4—Crohn's disease	3.61e-05	6.68e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PTGS2—Crohn's disease	3.58e-05	6.64e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—IL6—Crohn's disease	3.51e-05	6.5e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—IL6—Crohn's disease	3.51e-05	6.5e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL1B—Crohn's disease	3.49e-05	6.47e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL1B—Crohn's disease	3.49e-05	6.47e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—CD4—Crohn's disease	3.49e-05	6.47e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—CD4—Crohn's disease	3.49e-05	6.47e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PTGS2—Crohn's disease	3.47e-05	6.42e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PTGS2—Crohn's disease	3.47e-05	6.42e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ALB—Crohn's disease	3.45e-05	6.39e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ALB—Crohn's disease	3.44e-05	6.38e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ALB—Crohn's disease	3.43e-05	6.35e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TYK2—Crohn's disease	3.42e-05	6.34e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	3.39e-05	6.28e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TYK2—Crohn's disease	3.37e-05	6.23e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TYK2—Crohn's disease	3.36e-05	6.22e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ALB—Crohn's disease	3.32e-05	6.14e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ALB—Crohn's disease	3.32e-05	6.14e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TYK2—Crohn's disease	3.31e-05	6.12e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—JAK2—Crohn's disease	3.26e-05	6.04e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL6—Crohn's disease	3.23e-05	5.98e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—JAK2—Crohn's disease	3.21e-05	5.95e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—JAK2—Crohn's disease	3.2e-05	5.93e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—STAT3—Crohn's disease	3.16e-05	5.85e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—JAK2—Crohn's disease	3.15e-05	5.84e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—STAT3—Crohn's disease	3.13e-05	5.8e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—STAT3—Crohn's disease	3.03e-05	5.61e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTGS2—Crohn's disease	3.02e-05	5.59e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTGS2—Crohn's disease	3.01e-05	5.58e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTGS2—Crohn's disease	3e-05	5.56e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CXCL8—Crohn's disease	2.98e-05	5.52e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.93e-05	5.43e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—STAT3—Crohn's disease	2.93e-05	5.42e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—STAT3—Crohn's disease	2.93e-05	5.42e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CXCL8—Crohn's disease	2.92e-05	5.42e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTGS2—Crohn's disease	2.9e-05	5.38e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTGS2—Crohn's disease	2.9e-05	5.38e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	2.88e-05	5.33e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL6—Crohn's disease	2.83e-05	5.25e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TYK2—Crohn's disease	2.79e-05	5.18e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—STAT3—Crohn's disease	2.79e-05	5.18e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.79e-05	5.16e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL6—Crohn's disease	2.78e-05	5.15e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL6—Crohn's disease	2.74e-05	5.07e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.73e-05	5.05e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TYK2—Crohn's disease	2.7e-05	5.01e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TYK2—Crohn's disease	2.7e-05	5.01e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—STAT3—Crohn's disease	2.7e-05	5.01e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—STAT3—Crohn's disease	2.7e-05	5.01e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—JAK2—Crohn's disease	2.67e-05	4.94e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ALB—Crohn's disease	2.66e-05	4.93e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—Crohn's disease	2.61e-05	4.84e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ALB—Crohn's disease	2.6e-05	4.81e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—JAK2—Crohn's disease	2.58e-05	4.78e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—JAK2—Crohn's disease	2.58e-05	4.78e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—Crohn's disease	2.57e-05	4.77e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—Crohn's disease	2.45e-05	4.54e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL8—Crohn's disease	2.43e-05	4.51e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—Crohn's disease	2.4e-05	4.44e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—Crohn's disease	2.36e-05	4.37e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL8—Crohn's disease	2.35e-05	4.36e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL8—Crohn's disease	2.35e-05	4.36e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—Crohn's disease	2.35e-05	4.36e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—Crohn's disease	2.33e-05	4.31e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—Crohn's disease	2.31e-05	4.29e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—Crohn's disease	2.31e-05	4.28e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—Crohn's disease	2.27e-05	4.21e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—Crohn's disease	2.24e-05	4.15e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—Crohn's disease	2.24e-05	4.15e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—Crohn's disease	2.21e-05	4.09e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—Crohn's disease	2.19e-05	4.05e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.14e-05	3.97e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—Crohn's disease	2.11e-05	3.92e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—Crohn's disease	2.07e-05	3.84e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—Crohn's disease	2.05e-05	3.79e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—Crohn's disease	2.05e-05	3.79e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—Crohn's disease	1.96e-05	3.62e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—Crohn's disease	1.95e-05	3.61e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—Crohn's disease	1.91e-05	3.53e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—Crohn's disease	1.89e-05	3.51e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—Crohn's disease	1.89e-05	3.51e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—Crohn's disease	1.89e-05	3.5e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—Crohn's disease	1.89e-05	3.5e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.82e-05	3.36e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—Crohn's disease	1.67e-05	3.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.65e-05	3.05e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—Crohn's disease	1.64e-05	3.04e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—Crohn's disease	1.62e-05	2.99e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—Crohn's disease	1.6e-05	2.97e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.4e-05	2.59e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—Crohn's disease	1.37e-05	2.53e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—Crohn's disease	1.32e-05	2.45e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—Crohn's disease	1.32e-05	2.45e-05	CbGpPWpGaD
